JMV 332

cyclic analog of the C-terminal hexapeptide of CCK; functions as CCK/gastrin receptor agonist

Also Known As:

JMV-332; L-Phenylalaninamide, N2-acetyl-N6-(3-carboxy-1-oxopropyl)-L-lysylglycyl-L-tryptophyl-L-lysyl-L-alpha-aspartyl-, cyclic (1-4)-peptide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/01/1992 - "The interaction of the novel CCK analogs JMV-180, JMV-320, and JMV-332 with CCK-B/gastrin receptors on small cell lung cancer (SCLC) cells was investigated. "